| Product Code: ETC6663493 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Parkinsons Disease Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Parkinsons Disease Market - Industry Life Cycle |
3.4 Canada Parkinsons Disease Market - Porter's Five Forces |
3.5 Canada Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Canada Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Canada Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Canada Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Canada Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Canada Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Canada |
4.2.2 Technological advancements in diagnosis and treatment options |
4.2.3 Growing awareness and focus on Parkinson's disease research and development |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease medications and treatments |
4.3.2 Limited access to specialized healthcare services in certain regions of Canada |
4.3.3 Potential side effects and complications associated with current treatment options |
5 Canada Parkinsons Disease Market Trends |
6 Canada Parkinsons Disease Market, By Types |
6.1 Canada Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Canada Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Canada Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Canada Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Canada Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Canada Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Canada Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Canada Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Canada Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Canada Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Canada Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Canada Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Canada Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Canada Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Canada Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Canada Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Canada Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Canada Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Canada Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Canada Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Canada Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Canada Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Canada Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Canada Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Canada Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Canada Parkinsons Disease Market Export to Major Countries |
7.2 Canada Parkinsons Disease Market Imports from Major Countries |
8 Canada Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis for Parkinson's disease patients in Canada |
8.2 Number of clinical trials for new Parkinson's disease treatments in Canada |
8.3 Percentage of healthcare professionals trained in Parkinson's disease management in Canada |
9 Canada Parkinsons Disease Market - Opportunity Assessment |
9.1 Canada Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Canada Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Canada Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Canada Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Canada Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Canada Parkinsons Disease Market - Competitive Landscape |
10.1 Canada Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Canada Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here